At the top of that list, unsurprisingly, are Novo Nordisk obesity drugs Ozempic, Rybelsus, and Wegovy, all grouped together ...

Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...

Individuals with early-onset COPD and rapidly progressive pre-COPD frequently have a decades-long history of impaired ...

Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...

Novo Nordisk's Ozempic and Wegovy are among 15 drugs targeted for Medicare price negotiations in 2027. The U.S. aims to cut ...

Advocacy groups Friday cheered the new list of selected drugs and urged the Trump administration to continue the negotiations. Some Republicans have called for ending or overhauling the initiative ...

“Every time a new list (of drugs) comes out ... Ofev, which treats idiopathic pulmonary fibrosis. • Linzess, which treats chronic idiopathic constipation and irritable bowel syndrome with ...

The list prices of the top 25 drugs with the highest Medicare Part D spend that are not subject to drug price negotiations ...